T T Sreelekha Selected Research

galactoxyloglucan

2/2021	Corrigendum to ``Co-encapsulation of doxorubicin with galactoxyloglucan nanoparticles for intracellular tumor-targeted delivery in murine ascites and solid tumors'' [Translational Oncology 7 (2014), 525-536].
1/2021	Folic acid-appended galactoxyloglucan-capped iron oxide nanoparticles as a biocompatible nanotheranostic agent for tumor-targeted delivery of doxorubicin.
9/2019	Overcoming drug-resistance in lung cancer cells by paclitaxel loaded galactoxyloglucan nanoparticles.
3/2017	Computational and mechanistic studies on the effect of galactoxyloglucan: Imatinib nanoconjugate in imatinib resistant K562 cells.
2/2015	TRAIL-based tumor sensitizing galactoxyloglucan, a novel entity for targeting apoptotic machinery.
11/2014	Galactoxyloglucan-modified nanocarriers of doxorubicin for improved tumor-targeted drug delivery with minimal toxicity.
10/2014	Co-encapsulation of Doxorubicin with galactoxyloglucan nanoparticles for intracellular tumor-targeted delivery in murine ascites and solid tumors.
4/2014	Antitumor activity of galactoxyloglucan-gold nanoparticles against murine ascites and solid carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

T T Sreelekha Research Topics

Disease

23	Neoplasms (Cancer) 02/2021 - 12/2000
4	Ascites 02/2021 - 01/2014
3	Breast Neoplasms (Breast Cancer) 09/2019 - 01/2012
3	Leukemia 03/2017 - 01/2012
3	Carcinoma (Carcinomatosis) 04/2014 - 12/2000
2	Lung Neoplasms (Lung Cancer) 09/2019 - 11/2010
2	Neoplasm Metastasis (Metastasis) 08/2019 - 10/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016 - 02/2015
1	Nephrogenic Fibrosing Dermopathy 01/2021
1	Adenocarcinoma of Lung 09/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2017
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2016
1	Melanoma (Melanoma, Malignant) 01/2016
1	Candidiasis (Moniliasis) 04/2015
1	Lymphoma (Lymphomas) 01/2014
1	Nasopharyngeal Carcinoma 01/2012
1	Mouth Neoplasms (Oral Cancer) 10/2001
1	Carcinogenesis 10/2001
1	Adenoma (Adenomas) 12/2000

Drug/Important Bio-Agent (IBA)

8	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2021 - 11/2013
8	galactoxyloglucanIBA 02/2021 - 04/2014
7	Pharmaceutical PreparationsIBA 01/2021 - 01/2014
5	PST001IBA 01/2021 - 01/2012
5	Polysaccharides (Glycans)IBA 09/2020 - 01/2012
4	GoldIBA 01/2021 - 04/2013
4	NanoconjugatesIBA 01/2021 - 04/2014
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2021 - 04/2016
3	Antineoplastic Agents (Antineoplastics)IBA 02/2015 - 01/2012
2	Proteins (Proteins, Gene)FDA Link 09/2020 - 09/2019
2	galactomannanIBA 10/2018 - 10/2017
2	CaspasesIBA 10/2018 - 04/2016
2	Fluorouracil (Carac)FDA LinkGeneric 01/2014 - 01/2012
2	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 11/2010 - 10/2001
1	GadoliniumIBA 01/2021
1	Contrast MediaIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2021
1	MetalsIBA 09/2020
1	Therapeutic UsesIBA 09/2020
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 09/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2019
1	AntioxidantsIBA 10/2018
1	SilverIBA 10/2018
1	Vincristine (Oncovin)FDA LinkGeneric 10/2017
1	Imatinib Mesylate (Gleevec)FDA Link 03/2017
1	Biopolymers (Biopolymer)IBA 03/2017
1	bcr-abl Fusion ProteinsIBA 03/2017
1	liposomal doxorubicin (Doxil)FDA Link 04/2016
1	pseudopyronine BIBA 01/2016
1	Acridine OrangeIBA 01/2016
1	Ethidium (Ethidium Bromide)IBA 01/2016
1	Annexin A5IBA 01/2016
1	Anti-Infective Agents (Microbicides)IBA 04/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2015
1	Biological ProductsIBA 02/2015
1	LigandsIBA 02/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2014
1	xanthorrhizolIBA 01/2014
1	naphthaIBA 01/2014
1	marmelosinIBA 01/2014
1	Immunologic Factors (Immunomodulators)IBA 01/2012
1	Estradiol (Delestrogen)FDA LinkGeneric 11/2010
1	Estrogens (Estrogen)FDA Link 11/2010
1	Interleukin-6 (Interleukin 6)IBA 11/2010
1	CarcinogensIBA 10/2001
1	Isoleucine (L-Isoleucine)FDA Link 10/2001
1	Valine (L-Valine)FDA Link 10/2001
1	EnzymesIBA 10/2001
1	isoleucylvalineIBA 10/2001
1	Glycoproteins (Glycoprotein)IBA 12/2000
1	CarbohydratesIBA 12/2000
1	GlycoconjugatesIBA 12/2000
1	LectinsIBA 12/2000

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2021 - 01/2014
5	Therapeutics 01/2021 - 02/2015
1	Precision Medicine 09/2016
1	Immunomodulation 01/2012